FROM OUR PARTNERS
Boston’s hospital chiefs moonlight on corporate boards at rates far beyond the national level
More biotech and health care stories
Pfizer buys Seagen for $43 billion, boosts access to cancer drugs
Pfizer plans to let the biotech drug developer “continue innovating,” except with more resources than it would have alone, Pfizer chairman and CEO Albert Bourla told analysts.
VA to cover new Alzheimer’s drug
In an unexpected move, the Veterans Health Administration announced Monday that it will widely cover a new Alzheimer’s treatment, even as Medicare has decided to wait for additional data about the medicine before taking the same step.
R.I. health tech startup aims to reach pediatric anxiety patients where they are
Braver, founded by doctors at Bradley Hospital, deploys coaches to help in specific situations that kids may find challenging.
Telehealth at a crossroads: When does it work best? What should it cost?
The future of remote medical care remains unclear as patients flock back to the office, the rules shift once again, and insurers start to curtail their payments.
Waltham paid $17.4m for historic farmland. Now the city is placing a longtime community farm at risk, advocates say.
“I believe the citizens of Waltham should also have a chance to use this farm,” Mayor Jeannette McCarthy told city councilors at a recent meeting.
A deadly cancer you probably haven’t heard of is becoming more common. But a pioneering HIV activist is hoping to change that.
Merkel cell carcinoma is about five times more lethal than the better-known skin cancer, melanoma.
Juul to pay Chicago $23.8 million for underage vaping settlement
The Chicago Department of Public Health will use the money for youth prevention and reduction programs, education and outreach, according to a city press release.
Training program for life science careers draws $1 million donation
Developer Samuels & Associates is helping to fund a new biotech training program at Benjamin Franklin Cummings Institute of Technology.